Document is current
Any future updates will be listed below
-
Authors
Pavlicek, Vojtech
- License Information
-
More Information
Article History
Accepted: 20 February 2023
First Online: 13 March 2023
Interessenkonflikt
: V. Pavlicek: Teilnahme an „advisory boards“ für MSD, Sanofi Aventis, Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Eli-Lilly.
